Citizens reiterates Market Outperform on US Physical Therapy
Citizens analyst Constantine Davides has reiterated a Market Outperform rating for US Physical Therapy, maintaining a price target of $98.
*this image is generated using AI for illustrative purposes only.
Citizens analyst Constantine Davides has reaffirmed a Market Outperform rating for US Physical Therapy, maintaining a price target of $98. The rating reiteration signals continued confidence in the company's performance potential.
The analyst's stance supports the stock's current market trajectory, highlighting the firm's positive outlook. US Physical Therapy is listed on the NYSE under the ticker symbol USPH.
What upcoming catalysts could drive US Physical Therapy's stock toward the $98 price target?
How might changes in healthcare policy impact the company's growth trajectory?
What are the key risks that could challenge the analyst's optimistic outlook?
19
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
